ENvue Medical, Inc.
FEED
$0.81
-$0.02-2.01%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -18.07% | -0.20% | -18.41% | -30.66% | -6.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.07% | -0.20% | -18.41% | -30.66% | -6.60% |
| Cost of Revenue | 69.22% | 128.57% | 41.38% | 32.97% | 63.91% |
| Gross Profit | -122.34% | -89.85% | -58.92% | -65.56% | -38.30% |
| SG&A Expenses | 144.13% | 142.19% | 109.80% | 69.15% | 10.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 109.55% | 132.70% | 107.53% | 86.72% | 38.41% |
| Operating Income | -179.37% | -227.61% | -269.81% | -262.38% | -87.95% |
| Income Before Tax | -311.61% | -401.68% | -117.08% | -193.34% | -56.63% |
| Income Tax Expenses | -1,170.37% | -1,715.79% | 368.00% | 240.00% | -20.59% |
| Earnings from Continuing Operations | -303.59% | -390.82% | -119.11% | -193.75% | -55.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -303.59% | -390.82% | -119.11% | -193.75% | -55.81% |
| EBIT | -179.37% | -227.61% | -269.81% | -262.38% | -87.95% |
| EBITDA | -157.82% | -202.63% | -244.89% | -245.54% | -87.25% |
| EPS Basic | 78.47% | 52.11% | 30.45% | 49.46% | 47.34% |
| Normalized Basic EPS | 89.27% | 57.48% | 5.27% | 35.11% | 40.60% |
| EPS Diluted | 78.47% | 52.11% | 30.45% | 49.46% | 47.34% |
| Normalized Diluted EPS | 89.27% | 57.48% | 5.27% | 35.11% | 40.60% |
| Average Basic Shares Outstanding | 1,311.80% | 580.85% | 314.56% | 936.41% | 454.02% |
| Average Diluted Shares Outstanding | 1,311.80% | 580.85% | 314.56% | 936.41% | 454.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |